Beyond the Gut: Unveiling Butyrate's Global Health Impact Through Gut Health and Dysbiosis-Related Conditions: A Narrative Review.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic and secondary literature without systematic search or meta-analysis
PubMed 40284169 · doi:10.3390/nu17081305
What was done
This narrative review synthesized literature on the physiological roles of the short-chain fatty acid butyrate, focusing on its synthesis by gut microbiota, gut barrier preservation, systemic anti-inflammatory actions, metabolic modulation (obesity and type 2 diabetes), and neuroprotective pathways via the gut-brain axis.
What was found
The abstract reports no numerical data, effect sizes, or specific study counts. It describes mechanistic pathways showing that butyrate serves as a colonocyte energy source, preserves tight junctions, inhibits histone deacetylases (HDACs), and activates receptors such as FFAR3 and GPR109a, with potential therapeutic relevance across dysbiosis, metabolic disorders, and neurological conditions including Alzheimer's, Parkinson's, autism spectrum disorder, and Huntington's disease.
Why it matters
It highlights that microbiome-derived butyrate acts beyond local colonocyte nourishment, serving as a systemic signaling molecule with potential applications in metabolic and neurological diseases.
Limits
The paper is a narrative review with no systematic search criteria, risk-of-bias evaluation, or quantitative pooling. The abstract provides no empirical human trial data or clinical effect sizes, relying heavily on mechanistic and preclinical disease associations.
Cited by
- supports Dietary fiber is fermented by the gut microbiota into butyrate, which fuels and provides energy to colonocytes.